{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T15:11:20Z","timestamp":1795014680197,"version":"4.9.1"},"reference-count":54,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","award":["ECTZ206376"],"award-info":[{"award-number":["ECTZ206376"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["847939 (IP-cure-B project)"],"award-info":[{"award-number":["847939 (IP-cure-B project)"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2024,4,16]]},"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Achieving HBV cure will require novel combination therapies of direct-acting antivirals and immunomodulatory agents. In this context, the toll-like receptor 8 (TLR8) agonist selgantolimod (SLGN) has been investigated in preclinical models and clinical trials for chronic hepatitis B (CHB). However, little is known regarding its action on immune effectors within the liver. Our aim was to characterise the transcriptomic changes and intercellular communication events induced by SLGN in the hepatic microenvironment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>\n                      We identified\n                      <jats:italic>TLR8<\/jats:italic>\n                      -expressing cell types in the human liver using publicly available single-cell RNA-seq data and established a method to isolate Kupffer cells (KCs). We characterised transcriptomic and cytokine KC profiles in response to SLGN. SLGN\u2019s indirect effect was evaluated by RNA-seq in hepatocytes treated with SLGN-conditioned media (CM) and quantification of HBV parameters following infection. Pathways mediating SLGN\u2019s effect were validated using transcriptomic data from HBV-infected patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Hepatic\n                      <jats:italic>TLR8<\/jats:italic>\n                      expression takes place in the myeloid compartment. SLGN treatment of KCs upregulated monocyte markers (eg,\n                      <jats:italic>S100A12<\/jats:italic>\n                      ) and downregulated genes associated with the KC identity (eg,\n                      <jats:italic>SPIC<\/jats:italic>\n                      ). Treatment of hepatocytes with SLGN-CM downregulated\n                      <jats:italic>NTCP<\/jats:italic>\n                      and impaired HBV entry. Cotreatment with an interleukin 6-neutralising antibody reverted the HBV entry inhibition.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our transcriptomic characterisation of SLGN sheds light into the programmes regulating KC activation. Furthermore, in addition to its previously described effect on established HBV infection and adaptive immunity, we show that SLGN impairs HBV entry. Altogether, SLGN may contribute through KCs to remodelling the intrahepatic immune microenvironment and may thus represent an important component of future combinations to cure HBV infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2023-331396","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T13:16:15Z","timestamp":1714655775000},"page":"2012-2022","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":27,"title":["TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanism"],"prefix":"10.1136","volume":"73","clinical-trial-number":[{"clinical-trial-number":"nct04891770","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Armando Andres","family":"Roca Suarez","sequence":"first","affiliation":[{"name":"INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France"},{"name":"University of Lyon, Universit\u00e9 Claude-Bernard (UCBL), Lyon, France"},{"name":"The Lyon Hepatology Institute EVEREST, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Plissonnier","sequence":"additional","affiliation":[{"name":"INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France"},{"name":"University of Lyon, Universit\u00e9 Claude-Bernard (UCBL), Lyon, France"},{"name":"The Lyon Hepatology Institute EVEREST, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Grand","sequence":"additional","affiliation":[{"name":"INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France"},{"name":"University of Lyon, Universit\u00e9 Claude-Bernard (UCBL), Lyon, France"},{"name":"The Lyon Hepatology Institute EVEREST, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Michelet","sequence":"additional","affiliation":[{"name":"INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France"},{"name":"University of Lyon, Universit\u00e9 Claude-Bernard (UCBL), Lyon, France"},{"name":"The Lyon Hepatology Institute EVEREST, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Giraud","sequence":"additional","affiliation":[{"name":"INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France"},{"name":"University of Lyon, Universit\u00e9 Claude-Bernard (UCBL), Lyon, France"},{"name":"The Lyon Hepatology Institute EVEREST, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Saez-Palma","sequence":"additional","affiliation":[{"name":"INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France"},{"name":"University of Lyon, Universit\u00e9 Claude-Bernard (UCBL), Lyon, France"},{"name":"The Lyon Hepatology Institute EVEREST, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00eblle","family":"Dubois","sequence":"additional","affiliation":[{"name":"INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France"},{"name":"University of Lyon, Universit\u00e9 Claude-Bernard (UCBL), Lyon, France"},{"name":"The Lyon Hepatology Institute EVEREST, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Heintz","sequence":"additional","affiliation":[{"name":"INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France"},{"name":"University of Lyon, Universit\u00e9 Claude-Bernard (UCBL), Lyon, France"},{"name":"The Lyon Hepatology Institute EVEREST, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Diederichs","sequence":"additional","affiliation":[{"name":"INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France"},{"name":"University of Lyon, Universit\u00e9 Claude-Bernard (UCBL), Lyon, France"},{"name":"The Lyon Hepatology Institute EVEREST, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaas","family":"Van Renne","sequence":"additional","affiliation":[{"name":"Viral Hepatitis Research Group, Laboratory of Experimental Medicine and Pediatrics, Antwerp University, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Vanwolleghem","sequence":"additional","affiliation":[{"name":"Viral Hepatitis Research Group, Laboratory of Experimental Medicine and Pediatrics, Antwerp University, Antwerp, Belgium"},{"name":"Department of Gastroenterology and Hepatology, Antwerp University Hospital, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Daffis","sequence":"additional","affiliation":[{"name":"Gilead Sciences Inc, 324 Lakeside Dr, Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[{"name":"Gilead Sciences Inc, 324 Lakeside Dr, Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Kolhatkar","sequence":"additional","affiliation":[{"name":"Gilead Sciences Inc, 324 Lakeside Dr, Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Chun","family":"Hsu","sequence":"additional","affiliation":[{"name":"Center for Liver Diseases, E-Da Hospital\/I-Shou University, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J","family":"Wallin","sequence":"additional","affiliation":[{"name":"Gilead Sciences Inc, 324 Lakeside Dr, Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey H","family":"Lau","sequence":"additional","affiliation":[{"name":"Gilead Sciences Inc, 324 Lakeside Dr, Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon P","family":"Fletcher","sequence":"additional","affiliation":[{"name":"Gilead Sciences Inc, 324 Lakeside Dr, Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Rivoire","sequence":"additional","affiliation":[{"name":"INSERM U1032, Centre L\u00e9on B\u00e9rard (CLB), Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Levrero","sequence":"additional","affiliation":[{"name":"INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France"},{"name":"University of Lyon, Universit\u00e9 Claude-Bernard (UCBL), Lyon, France"},{"name":"The Lyon Hepatology Institute EVEREST, Lyon, France"},{"name":"Department of Hepatology, Croix Rousse hospital, Hospices Civils de Lyon, Lyon, France"},{"name":"Department of Internal Medicine - DMISM and the IIT Center for Life Nanoscience (CLNS), Sapienza University, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5588-5465","authenticated-orcid":false,"given":"Barbara","family":"Testoni","sequence":"additional","affiliation":[{"name":"INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France"},{"name":"University of Lyon, Universit\u00e9 Claude-Bernard (UCBL), Lyon, France"},{"name":"The Lyon Hepatology Institute EVEREST, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2245-0083","authenticated-orcid":false,"given":"Fabien","family":"Zoulim","sequence":"additional","affiliation":[{"name":"INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France"},{"name":"University of Lyon, Universit\u00e9 Claude-Bernard (UCBL), Lyon, France"},{"name":"The Lyon Hepatology Institute EVEREST, Lyon, France"},{"name":"Department of Hepatology, Croix Rousse hospital, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,5,2]]},"reference":[{"key":"2025120518522100000_73.12.2012.1","unstructured":"World Health Organization . Hepatitis B. 2022. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b [Accessed 22 Jan 2023]."},{"key":"2025120518522100000_73.12.2012.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"2025120518522100000_73.12.2012.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2211764"},{"key":"2025120518522100000_73.12.2012.4","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-022-00724-5"},{"key":"2025120518522100000_73.12.2012.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.12.007"},{"key":"2025120518522100000_73.12.2012.6","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12942"},{"key":"2025120518522100000_73.12.2012.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.10.027"},{"key":"2025120518522100000_73.12.2012.8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31795"},{"key":"2025120518522100000_73.12.2012.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.09.027"},{"key":"2025120518522100000_73.12.2012.10","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c00100"},{"key":"2025120518522100000_73.12.2012.11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31695"},{"key":"2025120518522100000_73.12.2012.12","doi-asserted-by":"crossref","DOI":"10.1038\/srep26157","article-title":"Cxcr6 marks a novel subset of T-betloEomeshi natural killer cells residing in human liver","volume":"6","author":"Stegmann","year":"2016","journal-title":"Sci Rep"},{"key":"2025120518522100000_73.12.2012.13","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20162115"},{"key":"2025120518522100000_73.12.2012.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.12.018"},{"key":"2025120518522100000_73.12.2012.15","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03733-14"},{"key":"2025120518522100000_73.12.2012.16","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2015.200"},{"key":"2025120518522100000_73.12.2012.17","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-022-00649-z"},{"key":"2025120518522100000_73.12.2012.18","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60761-688-7_3"},{"key":"2025120518522100000_73.12.2012.19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.232137699"},{"key":"2025120518522100000_73.12.2012.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.07.014"},{"key":"2025120518522100000_73.12.2012.21","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty560"},{"key":"2025120518522100000_73.12.2012.22","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0201-4"},{"key":"2025120518522100000_73.12.2012.23","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giab008","article-title":"Twelve years of Samtools and Bcftools","volume":"10","author":"Danecek","year":"2021","journal-title":"Gigascience"},{"key":"2025120518522100000_73.12.2012.24","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu638"},{"key":"2025120518522100000_73.12.2012.25","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-Seq data with Deseq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2025120518522100000_73.12.2012.26","unstructured":"Andrews S . Babraham Bioinformatics - FastQC A Quality Control tool for High Throughput Sequence Data, Available: https:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/ [Accessed 24 Jul 2023]."},{"key":"2025120518522100000_73.12.2012.27","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btw354"},{"key":"2025120518522100000_73.12.2012.28","doi-asserted-by":"publisher","DOI":"10.1038\/ng0506-500"},{"key":"2025120518522100000_73.12.2012.29","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btr260"},{"key":"2025120518522100000_73.12.2012.30","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0667-5"},{"key":"2025120518522100000_73.12.2012.31","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for Microarray and RNA-Seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"2025120518522100000_73.12.2012.32","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELL.2021.04.048"},{"key":"2025120518522100000_73.12.2012.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.12.025"},{"key":"2025120518522100000_73.12.2012.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.08.017"},{"key":"2025120518522100000_73.12.2012.35","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1631-3"},{"key":"2025120518522100000_73.12.2012.36","doi-asserted-by":"publisher","DOI":"10.1016\/J.IMMUNI.2022.08.002"},{"key":"2025120518522100000_73.12.2012.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.02.016"},{"key":"2025120518522100000_73.12.2012.38","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix683"},{"key":"2025120518522100000_73.12.2012.39","doi-asserted-by":"publisher","DOI":"10.1038\/srep43446"},{"key":"2025120518522100000_73.12.2012.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2021.04.009"},{"key":"2025120518522100000_73.12.2012.41","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium Taurocholate Cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"3","author":"Yan","year":"2012","journal-title":"Elife"},{"key":"2025120518522100000_73.12.2012.42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006839","article-title":"Viral manipulation of Stat3: evade, exploit, and injure","volume":"14","author":"Roca Suarez","year":"2018","journal-title":"PLoS Pathog"},{"key":"2025120518522100000_73.12.2012.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2015.02.026"},{"key":"2025120518522100000_73.12.2012.44","doi-asserted-by":"crossref","first-page":"S873","DOI":"10.1016\/S0168-8278(22)02041-4","article-title":"Bepirovirsen, Antisense Oligonucleotide (ASO) against hepatitis B virus (HBV), harbors intrinsic Immunostimulatory activity via toll-like receptor 8 (Tlr8) Preclinically, correlating with clinical efficacy from the phase 2A study","volume":"77","author":"You","year":"2022","journal-title":"Journal of Hepatology"},{"key":"2025120518522100000_73.12.2012.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2011.04.017"},{"key":"2025120518522100000_73.12.2012.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2023.10.003"},{"key":"2025120518522100000_73.12.2012.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.12.008"},{"key":"2025120518522100000_73.12.2012.48","unstructured":"Wu T , Wu D , Chen Y , et al . Efficacy and safety of combination treatment of Tlr7 agonist Tqa3334 and anti-PD-L1 Tqb2450 in Virally suppressed chronic hepatitis B patients: a pilot RCT phase II study (OCEAN Cure05 study). AASLD. 2023."},{"key":"2025120518522100000_73.12.2012.49","doi-asserted-by":"crossref","DOI":"10.1126\/science.abq5202","article-title":"Kupffer cell\u2013like Syncytia replenish resident macrophage function in the Fibrotic liver","volume":"381","author":"Peiseler","year":"2023","journal-title":"Science"},{"key":"2025120518522100000_73.12.2012.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.06.031"},{"key":"2025120518522100000_73.12.2012.51","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000438"},{"key":"2025120518522100000_73.12.2012.52","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2023.100841","article-title":"Evaluation of the HBV liver reservoir with fine needle Aspirates","volume":"5","author":"Testoni","year":"2023","journal-title":"JHEP Rep"},{"key":"2025120518522100000_73.12.2012.53","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1563"},{"key":"2025120518522100000_73.12.2012.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.02.028"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2023-331396","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T02:52:29Z","timestamp":1764989549000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2023-331396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":54,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,11,11]]},"published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1136\/gutjnl-2023-331396"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2023-331396","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,2]]}}}